Secondhand smoke may damage children’s eyes
(Reuters Health) – Secondhand smoke may damage children’s eyes and possibly lead to problems with sight later in life, new findings suggest. In a study of Chinese children, a structure…
Early life stress tied to increased pain sensitivity later
(Reuters Health) – People who were exposed to more sources of stress in the womb and early childhood may be more sensitive to pain by early adulthood than their counterparts…
Judge’s unorthodox approach has huge opioid settlement within reach
(Reuters) – From the start of the sprawling U.S. litigation seeking to hold drugmakers and distributors liable for the country’s opioid epidemic, Judge Dan Polster has made one thing clear:…
J&J recalls 33,000 bottles of baby powder as FDA finds asbestos in sample
(Reuters) – Johnson & Johnson said on Friday it is recalling around 33,000 bottles of baby powder in the United States after U.S. health regulators found trace amounts of asbestos…
Johnson & Johnson says baby powder investigation could take 30 days or more
(Reuters) – Johnson & Johnson said on Friday its investigation into asbestos contamination of its baby powder could take 30 days or more, after announcing it planned to recall about…
FDA approves Alexion’s Ultomiris for another rare blood disease
(Reuters) – The U.S. Food and Drug Administration on Friday approved Alexion Pharmaceuticals Inc’s treatment for a second rare blood disorder, the company said. The treatment, Ultomiris, has already been…
Opioid settlement talks fail, landmark trial expected Monday
CLEVELAND (Reuters) – A landmark trial over the U.S. opioid epidemic is on track to begin on Monday after drug companies and local governments failed to agree on a settlement…
Drug firms offer to settle U.S. opioid suits with $50 billion package – sources
(Reuters) – Five drugmakers and distributors are offering $22 billion in cash as well as drugs and services they value at $28 billion to resolve lawsuits alleging the industry helped…
Embattled drugmaker Indivior raises forecasts on Suboxone strength
(Reuters) – Indivior Plc on Tuesday raised its full-year forecasts as the embattled British drugmaker’s best-selling opioid addiction drug Suboxone fared better than expected in the face of competition from…
Fewer emergency surgeries, more deaths in British hospitals vs U.S.
(Reuters Health) – When patients in England or the U.S. have abdominal emergencies like appendicitis or a ruptured aneurysm, half as many in England get surgery and many more die,…